Promoting physiologic-physical adaptation in chronic obstructive pulmonary disease: pharmacotherapeutic evidence-based research and guidelines.

Guidelines from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and evidence-based research include advanced pharmacologic care for patients with chronic obstructive pulmonary disease (COPD). Although clinical trials of medications have not supported evidence that long-term decline in pulmonary function can be prevented, pharmacologic agents can reduce symptoms and prevent complications. High-quality home care services may improve quality of life and prevent hospital admissions because of acute exacerbations.